HTGM Insider Trading Activity and SEC Form 4 Filings
HTGM insider trading summary
No open-market insider purchases or sales of Htg Molecular Diagnostics, Inc (HTGM) have been reported on SEC Form 4 in the past 12 months.
Latest HTGM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 8, 2023 | Stephen Barat | Senior VP of Therapeutics | Sell | $710 (888 @ $0.80) |
| Dec 26, 2019 | Tim B Johnson | Executive Chairman | Sell | $4K (5,718 @ $0.72) |
| Dec 1, 2017 | Shaun D McMeans | VP, Finance & Admin. & CFO | Sell | $2K (945 @ $2.11) |
| Nov 1, 2017 | Shaun D McMeans | VP, Finance & Admin. & CFO | Sell | $2K (945 @ $2.26) |
| Oct 16, 2017 | Shaun D McMeans | VP, Finance & Admin. & CFO | Sell | $2K (946 @ $2.27) |
| Aug 25, 2017 | Novo Holdings A/S | 10% Owner | Sell | $1.3M (720,214 @ $1.75) |
| Aug 24, 2017 | Novo Holdings A/S | 10% Owner | Sell | $730K (382,437 @ $1.91) |
| Aug 23, 2017 | Novo Holdings A/S | 10% Owner | Sell | $95K (47,162 @ $2.02) |
| Aug 22, 2017 | Novo Holdings A/S | 10% Owner | Sell | $25K (12,641 @ $2.01) |
| Aug 21, 2017 | Novo Holdings A/S | 10% Owner | Sell | $26K (12,845 @ $2.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.